Robeco Institutional Asset Management B.V. Sells 3,078 Shares of Waters Corporation $WAT

Robeco Institutional Asset Management B.V. lowered its position in Waters Corporation (NYSE:WAT) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 25,941 shares of the medical instruments supplier’s stock after selling 3,078 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Waters were worth $9,853,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of WAT. Brighton Jones LLC boosted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares in the last quarter. Integrated Wealth Concepts LLC boosted its stake in Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in Waters by 3.6% in the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Empowered Funds LLC boosted its stake in Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in Waters in the second quarter worth $232,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Evercore raised Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price objective on the stock in a research note on Monday, April 6th. Citigroup assumed coverage on Waters in a research note on Tuesday, February 10th. They issued a “buy” rating and a $425.00 price objective on the stock. Wall Street Zen lowered Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Guggenheim reissued a “buy” rating and issued a $440.00 price objective on shares of Waters in a research note on Tuesday, February 10th. Finally, UBS Group reduced their price objective on Waters from $370.00 to $330.00 and set a “neutral” rating on the stock in a research note on Monday. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $387.53.

Waters Trading Down 1.3%

NYSE WAT opened at $326.56 on Thursday. The stock has a 50-day simple moving average of $313.97 and a 200 day simple moving average of $352.24. The company has a market capitalization of $32.06 billion, a PE ratio of 30.32, a P/E/G ratio of 2.10 and a beta of 1.20. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15.

Waters (NYSE:WAT) last released its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 EPS for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. The business had revenue of $932.36 million during the quarter, compared to the consensus estimate of $928.17 million. Waters had a return on equity of 34.79% and a net margin of 20.30%.The firm’s revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.10 earnings per share. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Research analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Insider Buying and Selling

In related news, Director Wei Jiang acquired 500 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The stock was acquired at an average price of $289.46 per share, for a total transaction of $144,730.00. Following the completion of the acquisition, the director owned 3,441 shares of the company’s stock, valued at $996,031.86. This trade represents a 17.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.63% of the company’s stock.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.